# Zithromax EV in Community-Acquired Pneumonia (CAP)

> **NCT00137007** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 151 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Ampicillin/sulbactam

## Key facts

- **NCT ID:** NCT00137007
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2011-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137007, "Zithromax EV in Community-Acquired Pneumonia (CAP)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00137007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*